In Vitro Diagnostics Market Research Reports & Industry Analysis
In Vitro Diagnostics Industry Research & Market Reports
-
Isothermal Nucleic Acid Amplification Technology (INAAT)
... reach US$6.7 Billion by 2030, growing at a CAGR of 10.2% over the analysis period 2024-2030. INAAT Reagents, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach ... Read More
-
Lab Automation Equipment and Software
... Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Automated Workstations, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$2.5 Billion ... Read More
-
Oncology Molecular Diagnostics
... at a CAGR of 11.1% over the analysis period 2024-2030. Breast Cancer Indication, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$2.9 Billion by the end ... Read More
-
Analytical Laboratory Services
... at a CAGR of 9.0% over the analysis period 2024-2030. Bioanalytical Testing Services, one of the segments analyzed in the report, is expected to record a 9.5% CAGR and reach US$273.4 Million by the end ... Read More
-
Autoimmune Disease Diagnosis
... at a CAGR of 6.0% over the analysis period 2024-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$4.1 Billion by the ... Read More
-
Bio-MEMS Devices
... CAGR of 16.7% over the analysis period 2024-2030. Implantables, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$18.2 Billion by the end of the analysis period. ... Read More
-
Blood Screening
... CAGR of 5.5% over the analysis period 2024-2030. Blood Screening Reagents & Kits, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.7 Billion by the end ... Read More
-
Cancer Diagnostics
... CAGR of 5.8% over the analysis period 2024-2030. Imaging, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$95.3 Billion by the end of the analysis period. ... Read More
-
Blood Transfusion Devices
... at a CAGR of 5.8% over the analysis period 2024-2030. Pathogen Reduction System, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.7 Billion by the end ... Read More
-
Blood Banking and Blood Products
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Blood Components & Plasma Products, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and ... Read More
-
Anatomic Pathology
... CAGR of 5.8% over the analysis period 2024-2030. Anatomic Pathology Services, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$36.4 Billion by the end of the ... Read More
-
Therapeutic Plasma Exchange
... at a CAGR of 6.2% over the analysis period 2024-2030. Neurological Disorders Indication, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$789.6 Million by the end ... Read More
-
Bio-MEMS
... 16.7% over the analysis period 2024-2030. Microfluidic Chips, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$27.4 Billion by the end of the analysis period. Growth ... Read More
-
Blood Transfusion Diagnostics
... at a CAGR of 4.7% over the analysis period 2024-2030. Blood Transfusion Diagnostic Instruments, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.7 Billion by the ... Read More
-
Cardiac Biomarkers
... CAGR of 7.3% over the analysis period 2024-2030. Troponins (T & I), one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$11.2 Billion by the end of ... Read More
-
Women`s Health Diagnostics
... at a CAGR of 5.8% over the analysis period 2024-2030. Breast Cancer Testing, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$11.3 Billion by the end ... Read More
-
Biomedical Refrigerators and Freezers
... 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Ultra Low Temperature (ULT) Freezers, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$533.2 ... Read More
-
Exocrine Pancreatic Insufficiency
... at a CAGR of 5.8% over the analysis period 2024-2030. Exocrine Pancreatic Insufficiency Therapeutics, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$4.8 Billion by the ... Read More
-
Automated Immunoassay Analyzers
... at a CAGR of 4.5% over the analysis period 2024-2030. Immunofluorescence Technology, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.2 Billion by the end of ... Read More
-
Blood Cell Analyzer
... at a CAGR of 4.8% over the analysis period 2024-2030. Semi-Automated Biochemistry Analyzers, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$687.6 Million by the end ... Read More
-
Cytology Brushes
... CAGR of 6.1% over the analysis period 2024-2030. Metal Brushes, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$71.9 Billion by the end of the analysis ... Read More
-
Pregnancy and Fertility Testing Products
... Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 10.7% CAGR The Pregnancy and Fertility ... Read More
-
Hematology Diagnostics
... CAGR of 5.8% over the analysis period 2024-2030. Hematology Diagnostic Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$7.8 Billion by the end of the ... Read More
-
Veterinary Molecular Diagnostics
... at a CAGR of 7.5% over the analysis period 2024-2030. Instruments & Software, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$342.8 Million by the end ... Read More
-
Immunoprotein Diagnostic Testing
... at a CAGR of 5.2% over the analysis period 2024-2030. Immunoglobulin Diagnostic Testing, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$6.4 Billion by the end ... Read More
Research Assistance
